Market Tracker

05/22 6:01pm ET

Theravance Inc (NASDAQ:THRX)

16.65
Delayed Data
As of May 22
 +0.34 / +2.08%
Today’s Change
10.58
Today|||52-Week Range
31.80
+17.67%
Year-to-Date
No recent news for Theravance Inc.

Today’s Trading

Previous close16.31
Today’s open16.29
Day’s range16.14 - 16.69
Volume475,031
Average volume (3 months)787,040
Market cap$1.9B
Dividend yield6.01%
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.11%
Earnings growth (next 5 years)-464.61%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+0.68+1.00%
IRWDIronwood Pharmaceuti...+0.05+0.36%
LCILannett Company Inc+0.66+1.21%
ADROAduro Biotech Inc-0.32-1.02%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts